Beta-arrestin-biased ligands at seven-transmembrane receptors (Q34654662)

3 August 2017

1 reference

title

Beta-arrestin-biased ligands at seven-transmembrane receptors (English)

1 reference

3 August 2017

main subject

transmembrane protein

0 references

1 reference

2

Robert J Lefkowitz

1 reference

3 August 2017

Jonathan D Violin

1

1 reference

3 August 2017

publication date

20 July 2007

1 reference

Trends in Pharmacological Sciences

3 August 2017

published in

1 reference

3 August 2017

volume

28

1 reference

3 August 2017

issue

8

1 reference

3 August 2017

page(s)

416-422

1 reference

beta-Arrestin: a protein that regulates beta-adrenergic receptor function

3 August 2017

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.2163110

An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Morphine side effects in beta-arrestin 2 knockout mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Morphine-activated opioid receptors elude desensitization by beta-arrestin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Selective signaling via unique M1 muscarinic agonists

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Techniques: promiscuous Galpha proteins in basic research and drug discovery

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Morphine activates opioid receptors without causing their rapid internalization

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Transduction of receptor signals by beta-arrestins

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Identification of allosteric peptide agonists of CXCR4.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

The BRET2/arrestin assay in stable recombinant cells: a platform to screen for compounds that interact with G protein-coupled receptors (GPCRS).

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Measurement of the millisecond activation switch of G protein-coupled receptors in living cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Rhodopsin: insights from recent structural studies.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Diversity in medicinal chemistry space

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Parathyroid hormone as an anabolic skeletal therapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Beta-arrestins and cell signaling

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Arrestins block G protein-coupled receptor-mediated apoptosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

When 7 transmembrane receptors are not G protein-coupled receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Target flexibility in molecular recognition

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

On the application of "a plausible model" of allosteric proteins to the receptor for acetylcholine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Enhanced morphine analgesia in mice lacking beta-arrestin 2

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

A β-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor Activation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

New concepts in drug discovery: collateral efficacy and permissive antagonism

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

G protein-coupled receptor kinase and beta-arrestin-mediated desensitization of the angiotensin II type 1A receptor elucidated by diacylglycerol dynamics.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

A potential novel strategy to separate therapeutic- and side-effects that are mediated via the same receptor: beta-arrestin2/G-protein coupling antagonists

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.TIPS.2007.06.006

Identifiers

DOI

10.1016/J.TIPS.2007.06.006

1 reference

3 August 2017

1 reference